This list is an analysis based on recent market events. It's not an investment recommendation.
SyntekaBio, Inc. operates as an artificial intelligence new drug development company based on genomic big data primarily in South Korea. It derives new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology. The company also researches and develops biomarker detection for individual cancer drug screening, disease susceptibility, immune typing, pharmacogenomic typing, and multi-omics information-based drug side effect prediction technology. The company was founded in 2009 and is headquartered in Daejeon, South Korea.
FAQs
What is SyntekaBio stock price today?▼
The current price of 226330.KQ is ₩985 KRW — it has decreased by -0.71% in the past 24 hours. Watch SyntekaBio stock price performance more closely on the chart.
What is SyntekaBio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange SyntekaBio stocks are traded under the ticker 226330.KQ.
Is SyntekaBio stock price growing?▼
226330.KQ stock has fallen by -10.86% compared to the previous week, the month change is a -22.2% fall, over the last year SyntekaBio has showed a -75.16% decrease.
What is SyntekaBio market cap?▼
Today SyntekaBio has the market capitalization of 23.89B
When is the next SyntekaBio earnings date?▼
SyntekaBio is going to release the next earnings report on November 18, 2026.
What is SyntekaBio revenue for the last year?▼
SyntekaBio revenue for the last year amounts to 3.43B KRW.
What is SyntekaBio net income for the last year?▼
226330.KQ net income for the last year is -17.38B KRW.
How many employees does SyntekaBio have?▼
As of November 3, 2026, the company has 52 employees.
In which sector is SyntekaBio located?▼
SyntekaBio operates in the Energy sector.
When did SyntekaBio complete a stock split?▼
SyntekaBio has not had any recent stock splits.
Where is SyntekaBio headquartered?▼
SyntekaBio is headquartered in Daejeon, South Korea.